Attenuation of hyperinsulinemia in polycystic ovary syndrome: what are the options?
Ehrmann
D A
DA
Department of Medicine, University of Chicago, IL 60637, USA.
D002839:Chromans / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications / Q000188:drug therapy*; D007004:Hypoglycemic Agents; D008687:Metformin / Q000627:therapeutic use; D011085:Polycystic Ovary Syndrome / Q000209:etiology* / Q000628:therapy; D013844:Thiazoles / Q000627:therapeutic use; D045162:Thiazolidinediones; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D008687:Metformin; D000077288:Troglitazone